{"data":{"ticker":"NTLA","name":"Intellia Therapeutics, Inc.","cik":"0001652130","quarterly":[{"frame":"CY2023Q3","end":"2023-09-30","revenue":11992000,"netIncome":-122224000,"epsDiluted":-1.38,"fiscalPeriod":"Q3 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2023Q4","end":"2023-12-31","revenue":-1917000,"netIncome":-132161000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2024Q1","end":"2024-03-31","revenue":28935000,"netIncome":-107436000,"epsDiluted":-1.12,"fiscalPeriod":"Q1 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q2","end":"2024-06-30","revenue":6957000,"netIncome":-146975000,"epsDiluted":-1.52,"fiscalPeriod":"Q2 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q3","end":"2024-09-30","revenue":9111000,"netIncome":-135712000,"epsDiluted":-1.34,"fiscalPeriod":"Q3 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q4","end":"2024-12-31","revenue":12874000,"netIncome":-128898000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2025Q1","end":"2025-03-31","revenue":16627000,"netIncome":-114329000,"epsDiluted":-1.1,"fiscalPeriod":"Q1 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q2","end":"2025-06-30","revenue":14245000,"netIncome":-101255000,"epsDiluted":-0.98,"fiscalPeriod":"Q2 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q3","end":"2025-09-30","revenue":13782000,"netIncome":-101324000,"epsDiluted":-0.92,"fiscalPeriod":"Q3 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q4","end":"2025-12-31","revenue":23017000,"netIncome":-95786000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2026Q1","end":"2026-03-31","revenue":15048000,"netIncome":-96231000,"epsDiluted":-0.81,"fiscalPeriod":"Q1 FY 2026","fiscalYear":"FY 2026"},{"frame":"CY2026Q2","end":"2026-06-30","revenue":7659000,"netIncome":-106634000,"epsDiluted":-0.8,"fiscalPeriod":"Q2 FY 2026","fiscalYear":"FY 2026"}],"annual":[{"frame":"CY2020","end":"2020-12-31","fiscalYear":"FY 2020","revenue":57994000,"netIncome":-134231000,"operatingCashFlow":-49912000,"capex":3585000,"buybacks":null,"dividends":null},{"frame":"CY2021","end":"2021-12-31","fiscalYear":"FY 2021","revenue":33053000,"netIncome":-267892000,"operatingCashFlow":-225030000,"capex":12756000,"buybacks":null,"dividends":null},{"frame":"CY2022","end":"2022-12-31","fiscalYear":"FY 2022","revenue":52121000,"netIncome":-474186000,"operatingCashFlow":-333287000,"capex":13558000,"buybacks":null,"dividends":null},{"frame":"CY2023","end":"2023-12-31","fiscalYear":"FY 2023","revenue":36275000,"netIncome":-481192000,"operatingCashFlow":-394086000,"capex":13985000,"buybacks":null,"dividends":null},{"frame":"CY2024","end":"2024-12-31","fiscalYear":"FY 2024","revenue":57877000,"netIncome":-519021000,"operatingCashFlow":-348880000,"capex":5778000,"buybacks":null,"dividends":null},{"frame":"CY2025","end":"2025-12-31","fiscalYear":"FY 2025","revenue":67671000,"netIncome":-412694000,"operatingCashFlow":-394736000,"capex":1129000,"buybacks":null,"dividends":null}],"latest":{"end":"2026-06-30","cash":106128000,"debt":null,"equity":727706000,"assets":857164000,"sharesOutstanding":140126693,"sharesDate":"2026-07-31","form":"10-Q"},"source":"SEC XBRL companyfacts, values as filed in USD"},"updatedAt":"2026-10-14T22:48:04.834Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Financial statement data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}